News

The platform delivers data management, organization and subsequent connection with downstream development, while supporting regulatory compliance and protecting intellectual property. It incorporates the ability to search across experiments,

As part of the agreement, Catalent will engineer a cell line expressing Nascent’s Pritumumab antibody using Catalent’s GPEx technology. Catalent will produce purified monoclonal antibody to support Nascent’s

Blood test was initially cleared to diagnose and distinguish methicillin resistant and methicillin sensitive Staphylococcus aureus (MRSA vs. MSSA) in positive blood cultures. The test is now cleared

As per the agreement, Vanda will pay an initial license fee of $1m to Eli Lilly and will be responsible for all development costs. Lilly is also eligible

The deal is expected to provide Spectrum with access to line of organics for biochemical, R&D, medicinal chemistry and general laboratory use and enhances the Spectrum’s chemical offering

As per the agreement, Conformetrix’s technology will be applied across AstraZeneca’s pre-clinical therapeutic pipeline to enhance lead discovery and hit identification. The technology will also be used to

As per the transaction, entire share and equity interest of Eisai Machinery is transferred to the Bosch Group. Eisai’s machinery business is specialized in the manufacture, sales and

The ADX71441 compound, analyzed in female guinea pigs with bladder overactivity, induced an increase in inter contraction interval, a validated measure of bladder muscle control, in the first

The products achieved the target pharmacokinetic, pharmacodynamic and toleration profiles in a Phase I trial and BIOD-123 is expected to advance to Phase II in the third calendar